How Humans Evolved a Starch-Digesting Superpower Long Before Farming

Picture of Patrick Wang

Patrick Wang

Expert of Peptides | Ask me anything about Peptides | Sales Manager at AHB Lab
cover

Table of Contents

If you’ve ever felt a rush of energy after consuming a thick slice of bread or a roasted yam, you should be thankful for an amazing genetic mutation that occurred in our ancestors hundreds of thousands of years ago. Recent research has uncovered how humans evolved to become better starch digesters and how such an evolutionary trait, as it would turn out, actually predates the birth of agriculture by a long shot.

Indeed, two landmark studies-one in Nature and the other in Science-shed light on how the gene responsible for digestion of starch, AMY1, has evolved. This gene helps in the production of the enzyme amylase, which acts on starch in our mouth and breaks it down to sugars. Investigations not only delve into when this gene first duplicated but also reveal how the rise of agriculture has massively influenced its evolution.

 

The Starch-Digesting Gene: AMY1

The gene responsible for salivary amylase, AMY1, begins the digestion of starch by producing amylase in the saliva. Modern humans have multiple copies of this gene, and populations with high-starch diets-whether from grains or tubers-tend to have even more copies. This allows them to extract even more energy out of starchy foods; this trait has doubtlessly played a key role in survival within a population.

Until now, however, the origins of this gene duplication, and why AMY1 has become so prone to multiple copies, had remained unresolved. The following recent studies add a great deal to the previous knowledge about the timing of duplication and its genetic mechanism, therefore unraveling the evolutionary journey of starch-digestive capabilities in humans.

 

The Evolution of AMY1: Conflicting Timelines

While the two studies agree on the general outlines of how AMY1 evolved, they disagree on precisely when the gene first duplicated. Using one of the studies, from Peter Sudmant of the University of California, Berkeley, the gene duplication is pegged at roughly 279,000 years ago, long before agriculture took root. The other, led by Charles Lee from the Jackson Laboratory and Omer Gokcumen from the University at Buffalo, offers an even earlier timeline: perhaps the gene duplicated as long ago as 800,000 years.

That’s a striking difference, yet it does nothing to contradict the central findings: both studies confirm that agriculture’s rise did indeed affect the number of AMY1 copies found in modern-day humans.

 

Agriculture and the Surge of AMY1

Agriculture, which began around 12,000 years ago, turned wheat, yams, and rice into food staples. As these starch-rich crops became more common, people who carried extra copies of the AMY1 gene were better adapted to digesting starch and absorbing nutrition from them. In essence, the shift toward agricultural diets triggered an explosive proliferation of AMY1 gene copies in successive generations, both teams report.

The Sudmant-led study examined the genomes of 519 ancient Eurasians to go back 12,000 years. The team believed that an average of four to over seven copies of AMY1 per person increased about 5,000 years ago when agriculture spread across Europe and Asia. The increased copy number of AMY1 was a striking example of natural selection for the ability to convert starch into energy more efficiently, which helped early individuals survive and reproduce in agrarian societies.

 

Neanderthals and Denisovans: Did They Have AMY1 Duplications?

The question for the research was whether human relatives such as Neanderthals and Denisovans also carried multiple copies of the AMY1 gene. As these new studies explain, the answer is complicated.

However, Sudmant’s team found no evidence of duplicated copies of the gene in the genomes of three Neanderthals and one Denisovan. By contrast, the work of Lee and Gokcumen indicates another scenario: duplications of the gene AMY1 in some Neanderthals and Denisovans. This would suggest either that the gene duplications occurred far earlier than previously thought, or that those ancient relatives had acquired the gene copies through interbreeding with modern humans.

Whatever the exact timing, it is clear that AMY1 duplications have been a part of the human genome for a long period and such gene copies most probably played an important role in enabling early humans and their relatives to adapt to different dietary environments.

 

Why is AMY1 So Prone to Duplication?

One of the big contributions of the new studies is to explain how easily the AMY1 gene duplicates. The work by Lee and Gokcumen shows that once a specific version of the gene-a “three-copy haplotype”-arose, it served as a template for further duplications. Because of the way gene copies were arranged on the chromosomes, a process called crossing over was possible, in which DNA from two copies could mingle and copy itself.

This process explains how some populations came to have considerably more copies of the gene, while others suffered deletions. “The moment we have the three-copy haplotype, it’s the steppingstone for the evolution of this locus-we can either go up by two copies or we can go down by two,” says Charikleia Karageorgiou, a postdoctoral researcher and co-author on the study.

 

Implications for Evolutionary Biology

The revelation of duplication mechanisms of the AMY1 gene provides a wider understanding of how structural variations in the genome contribute to human evolution. “These findings are very exciting,” says Diyendo Massilani, a geneticist at Yale University, who adds that it could spur further research into how gene copy number variations have driven human adaptation. This research could also yield some clues toward understanding other genetic conditions related to gene copy number, such as Huntington’s disease.

This ability to digest starch more effectively has clearly been a valuable trait for humans over the millennia, helping to fuel the rise of agriculture and to support growing populations. And as researchers continue to unravel the many complexities in our evolutionary history, it would seem genes like AMY1 have played a very important role in shaping who we are today.

 

Conclusion

The evolution of the AMY1 gene and this starch digestion superpower give an exciting glimpse into the dynamics of human adaptability. With the timeline of duplication of AMY1 still under debate, one thing is for sure: such a genetic trait has played an important role in human survival and dietary evolution. From the first mutations that allowed early humans to digest starch a little better, through the agricultural revolution that multiplied AMY1 gene copies manyfold, this genetic story is one of resilience and adaptation.

As researchers continue to learn more about the subject, we piece together a complex puzzle of just how our ancestors evolved to develop the tools needed for them to thrive on a diet based on starchy foods, a capability that shaped human history.

At AHB Lab, we’re committed to keeping you informed on these crucial developments and their impact on our industry. Stay tuned for more insights as the election progresses!

Leave a Reply

Your email address will not be published. Required fields are marked *

公司最新訊息

科學定義年輕:打破濃度天花板,突破 50 倍胜肽的微觀保養新標準

迷思破解:你臉上敷的是保養品,還是昂貴的「安慰劑」? 看著鏡子裡的自己,你是否也曾陷入「只要表面沒有皺紋,就是年輕」的迷思?你是否花了大筆預算購買頂級抗老精華,擦了大半年卻發現保養效果總是陷入停滯 ?  許多品牌與消費者花費大筆金錢,卻彷彿只是在臉上塗了一層「昂貴保鮮膜」,這種「食之無味,棄之可惜」的瓶頸,是許多消費者與品牌端共同的痛點。 其實,真正的年輕從來不是表面看起來沒有皺紋,而是細胞正在健康、充滿活力地運作,你每天精心塗抹的,很可能只是一劑帶來心理安慰的「安慰劑」。 關鍵往往不在於產品「有沒有加」抗老成分,而在於「有沒有達到有效濃度」。 濃度即是真理:為什麼傳統胜肽經常淪為微弱的 Wi-Fi? 為了理解這個現象,我們必須從胜肽的製造工藝說起 。 傳統的抗老胜肽大多仰賴化學合成,其原料成本極其高昂,在巨大的成本壓力下,市面上多數保養品所使用的胜肽原料濃度往往只有 100 ppm,經過常規稀釋加進產品後,真正作用在皮膚上的只剩下微乎其微的 10 ppm。 這 10 ppm 的微弱訊號就像隨時會斷線的 Wi-Fi,根本無法穿透皮膚防火牆去啟動細胞修復。 當「兵力」不夠,面對成千上萬的老化細胞,低濃度保養幾乎等同於白做工,然而,最新的生技突破為這場微觀災難帶來了轉機。 AHB Lab 透過先進的細胞級生物工程與獨家的微生物發酵平台,成功研發出「第3代生物合成肽」,一舉突破傳統化學合成的成本極限,這項技術將原料濃度強勢拉高到驚人的 5000

Read More
公司最新訊息

為什麼傳統控糖策略總是陷入瓶頸?揭開「定序 9 胜肽」突破停滯期的細胞級密碼

當鑰匙過剩,而鎖卻壞了 在現代代謝健康管理中,許多患者與醫療專業人員面臨著一個共同的挫折:為什麼藥越吃越重,血糖卻依然像脫韁野馬一樣失控? 傳統的思維往往認為,只要乖乖吞下藥丸,強制刺激身體分泌更多的「胰島素」,數字總有一天會降下來 。然而,第二型糖尿病最殘酷的現實是,患者體內根本不缺胰島素這把「鑰匙」,而是細胞表面負責接收訊號的「鎖」壞掉了,這就是醫學上常說的「胰島素阻抗」。 當這把鎖壞了,糖分通道的大門緊閉,製造再多鑰匙也打不開大門,導致葡萄糖死死堵在血管裡,而細胞卻在極度挨餓 。更糟的是,長期依賴單一機制強制壓低數字,不僅無法修復細胞受損的接收器,還可能讓患者承受肝腎負擔加重的無形恐懼,甚至面臨瞬間失去意識的低血糖暈眩風險 。 有沒有一種方法,能夠不依賴傳統的「暴力壓制」,而是從細胞根源溫和且精準地重啟代謝通道?答案,就藏在尖端生物科技的「胜肽(Peptide)」技術中 。 什麼是「定序 9 胜肽」?它如何從細胞根源解決問題? 為了解決這把「壞掉的鎖」,科學家們將目光轉向了天然植物胜肽。經過多年的心血,研發團隊成功從高達 320 公斤的特定品種苦瓜中,極致濃縮精煉出 1 公斤的活性能量,並成功解碼出一段分子量僅有 640 Da 的「定序 9 胜肽(苦瓜九肽)」。 這段微小胜肽在體內扮演著「超級備用鑰匙」的角色 。它具有極高的生物利用度(Bioavailability),能夠直接繞過細胞表面那把壞掉的鎖,強制啟動受器,精準推開緊閉的糖通道大門 。

Read More
公司最新訊息

為什麼吃再多苦瓜也降不了血糖?解密「苦瓜九肽」的科學真相與控糖未來

血糖失控的真相與苦瓜迷思 在台灣,糖尿病是一個影響著超過兩百萬人的嚴重健康問題 。面對居高不下的血糖數字,許多人經常尋求民間偏方,其中最常見的巨大迷思就是:「吃苦瓜就能降血糖嗎?」 。 答案是:錯的! 如果您或您的消費者只是單純地大量食用苦瓜,不僅有效成分極難被人體吸收,攝取過多的苦瓜纖維甚至會被轉換為醣類,導致血糖不降反升 。單純吃天然食物與實現真正的「醫療級改善」,這中間存在著巨大的科學鴻溝。今天,我們將從生物機制的底層邏輯出發,為您揭開血糖失控的真相,並探討科學界如何透過先進的生技技術,真正利用苦瓜胜肽來逆轉這個局面。 為什麼傳統苦瓜萃取物無效? 要理解市售產品為何無效,我們必須先釐清細胞代謝的底層邏輯。 核心機制:胰島素阻抗的「鎖與鑰匙」 當我們進食後,食物會轉化為葡萄糖進入血管,導致血糖升高 。此時,胰臟會分泌一種稱為「胰島素」的激素 。 在細胞生物學中,這是一個優雅的機制: 鑰匙:您可以把胰島素想像成一把鑰匙 。 鎖:在細胞表面,存在著被稱為「胰島素受器」的鎖孔 。 開門:當鑰匙(胰島素)順利插入鎖(受器)時,會發出訊號,打開旁邊的「糖通道」大門 。血管裡的葡萄糖便能順利進入細胞轉化為能量,血糖自然就會下降 。 然而,對於第二型糖尿病患者而言,問題不在於缺乏鑰匙(胰島素分泌足夠),而是「鎖(受器)壞掉了」 。這在醫學上被定義為「胰島素阻抗」 。因為鎖壞了,糖通道的大門打不開,導致葡萄糖全部阻塞在血管中,造成血糖居高不下,而細胞本身卻處於挨餓狀態 。

Read More